Open AccessFrailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation
Author(s) -
Dae Hyun Kim,
Ajinkya Pawar,
Joshua J. Gagne,
Lily G. Bessette,
Hemin Lee,
Robert J. Glynn,
Sebastian Schneeweiß
Publication year - 2021
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m20-7141
Subject(s) - medicine , rivaroxaban , dabigatran , warfarin , atrial fibrillation , hazard ratio , apixaban , cohort , stroke (engine) , propensity score matching , cohort study , proportional hazards model , cardiology , anesthesia , confidence interval , mechanical engineering , engineering
The role of differing levels of frailty in the choice of oral anticoagulants for older adults with atrial fibrillation (AF) is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom